• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

UBRF: UberBrain Research Frontier

Meeting the Challenge of Healthcare Transformation

  • About
    • Research Frontiers
    • Vision & Mission
    • Our Manifesto
  • Team
    • Vivek Misra
    • Poornima Rajan-Misra
  • Core Services
    • Research Consulting
    • Innovation Management
  • Work
    • Publications
    • White Papers
  • Journal
  • Contact

May 20, 2013 By Vivek Misra Leave a Comment

Epilepsy Service Organization in Countries with Limited Resources

tumblr: bellapaige88
tumblr: bellapaige88

On average, 9.5/1000 population has epilepsy in Low and Middle Income Countries (LAMIC). A research which has resulted in the global campaign against epilepsy has shown, the gap between treatment need and the treatment provision worldwide is approximately 70% [1]. This large ‘treatment gap’, i.e., lack of appropriate treatment for a large number of patients with epilepsy, due to a number of causes including inability to identify cases, inability to deliver adequate treatment, people’s attitudes and perception, availability of anti-epileptic drugs and finally, health policies of individual countries and the priority given to epilepsy. [2]

The first step towards narrowing the treatment gap is improving diagnosis. Clinical investigations that help in the diagnosis of epilepsy include electroencephalography (EEG), neuro-imaging techniques such as computed axial tomograpy (CT) and magentic resonance imaging (MRI). Simple blood tests, including haematological, liver and kidney function profiles can reveal treatable causes of epilepsy, such as parasitic infections. Neuropsychological evaluation identifies areas of function and dysfunction. Long term video monitoring can greatly improve the diagnosis of epilepsy. Therapeutic drug monitoring can ensure that patients are receiving optimal doses of medication and can help greatly in avoiding toxicity. However, the availability of investigative procedures varies greatly, from 82.4% for EEG, 70.5% for CT, 45% for therapeutic drug monitoring  to only 20.6 % for MRI, 21.7% for long-term video monitoring and in LAMICs. Special investigations of brain function such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) are not available in most LAMIC centres.

Epilepsy services in low and middle income countries are almost non-existent and service organization is a challenge. Epilepsy services should be community based and it is important to integrate these services into the primary health care structure to ensure sustainability. The Indian model is one such example, where epilepsy care has been incorporated into programmes for poverty alleviation [3]. Public-private partnerships and non-governmental organizations (NGO) are also important components of the Indian model. [4]

The ultimate goal of all workers in the epilepsy field is to improve the quality of the life of people with epilepsy and their families. The prime manner in which this is aimed for is by the provision of good medical care.

 

ResearchBlogging.org
Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, Yuan CL, Scott RA, Prilipko LL, de Boer HM, & Sander JW (2003). The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology, 60 (9), 1544-5 PMID: 12743252

Mbuba CK, Ngugi AK, Newton CR, & Carter JA (2008). The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia, 49 (9), 1491-503 PMID: 18557778 Pal, D., Das, T., & Sengupta, S. (2000). 

Case-control and qualitative study of attrition in a community epilepsy programme in rural India Seizure, 9 (2), 119-123 DOI: 10.1053/seiz.1999.0357

Mani KS, Rangan G, Srinivas HV, Srindharan VS, & Subbakrishna DK (2001). Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study. Lancet, 357 (9265), 1316-20 PMID: 11343735

Mbuba CK, Ngugi AK, Newton CR, & Carter JA (2008). The epilepsy treatment gap in developing countries: a systematic review of the magnitude, causes, and intervention strategies. Epilepsia, 49 (9), 1491-503 PMID: 18557778

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pocket
  • WhatsApp
  • Reddit
  • More
  • Tumblr
  • Pinterest
  • Email
  • Print

Filed Under: Mental Health Tagged With: Health Policy

Vivek Misra

Clinical Neuroscientist | Founder Uberbrain Research Frontier.
Join Me: Twitter / LinkedIN

Reader Interactions

Leave a Reply Cancel reply

Primary Sidebar

Email Newsletter

Get The UberBrain in Your Inbox!

Trends

  • Clinical Neuroscience
  • Healthcare
  • Medical Technology
  • Mental Health
  • Neuromodulation

Recent Posts

  • What is Transcutaneous Vagus Nerve Stimulation (tVNS)?
  • What is Transcranial Direct Current Stimulation?
  • What is Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy?

Footer

Contact Us

Email – info [at] ubrf.org

9444 222 050

About Us

UBRF develops Strategies and Innovation Systems focused upon Neuroscience and Mental Health Research.

Learn More.

Follow Us

  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Copyright © 2023 Uberbrain Research Frontier

  • Terms Of Use
  • Medical Disclaimer
  • Privacy Policy